WASATCH ADVISORS
Wasatch Advisors is an investment management company specializing in equity funds. The company manages institutional and individual portfolios. The company was formed in 1975 by Sam Stewart and still follows his philosophy of a bottom-up research method that focuses on long-term growth and finding market inefficiencies. Wasatch Advisors maintains its headquarters at Salt Lake City, Utah.
WASATCH ADVISORS
Social Links:
Industry:
Financial Exchanges Financial Services Venture Capital
Founded:
1975-01-01
Status:
Active
Technology used in webpage:
SPF Microsoft Azure DNS IIS 10 GoDaddy SSL Unified Layer Network Solutions DNS Zoom Video Conferencing Zoom BlueHost Proofpoint
Similar Organizations
Amasia
Amasia is a venture capital investment firm that invests from Seed to Series B stages.
CDH Investments
CDH Investments is an international alternative asset fund manager with more than $2.0 billion of committed capital under management.
Color Capital
Color Capital invests in things people buy, and how they buy them.
Zeev Ventures
Zeev Ventures is an early-stage venture fund that invests in technology, financial, e-commerce, and consumer service sectors.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-07-17 | Frequency Therapeutics | Wasatch Advisors investment in Post-IPO Equity - Frequency Therapeutics | 42.3 M USD |
| 2019-02-28 | Medallia | Wasatch Advisors investment in Series F - Medallia | 70 M USD |
| 2016-06-28 | Quess Corp | Wasatch Advisors investment in Venture Round - Quess Corp | 26.5 M USD |
| 2015-05-12 | DocuSign | Wasatch Advisors investment in Series F - DocuSign | 300 M USD |
| 2014-09-04 | DataStax | Wasatch Advisors investment in Series E - DataStax | 106 M USD |
| 2009-11-09 | Tethys BioScience | Wasatch Advisors investment in Series D - Tethys BioScience | 25 M USD |
| 2008-02-20 | Incipient | Wasatch Advisors investment in Series E - Incipient | 15.6 M USD |
| 2008-02-20 | Ocera Therapeutics | Wasatch Advisors investment in Series C - Ocera Therapeutics | 35.5 M USD |
| 2007-03-27 | Orqis Medical | Wasatch Advisors investment in Series D - Orqis Medical | 12 M USD |
| 2007-01-08 | Standard BioTools | Wasatch Advisors investment in Series E - Standard BioTools | 37 M USD |